CPT® Code 81551

1. Indications

The procedure associated with CPT® Code 81551 is indicated for the assessment of prostate cancer, particularly in situations where there is a need to evaluate the likelihood of cancer presence following a negative biopsy result. The following conditions may warrant the use of this test:

• Prostate Cancer Suspicion Patients exhibiting clinical signs or symptoms suggestive of prostate cancer may require this test to confirm or rule out the disease.
• Negative Biopsy Results Individuals who have undergone a prostate biopsy that returned negative results but still have a high clinical suspicion of cancer may benefit from this test to identify potential false negatives.
• Monitoring Recurrence Patients with a history of prostate cancer may be monitored for recurrence, and this test can provide additional information regarding the presence of cancerous changes.

2. Procedure

The procedure for CPT® Code 81551 involves several critical steps to ensure accurate molecular genomic testing. The following outlines the procedural steps:

• Step 1: Sample Collection A formalin-fixed paraffin-embedded tissue sample is obtained from the prostate tumor. This sample is essential for the subsequent analysis, as it preserves the cellular architecture and molecular integrity necessary for testing.
• Step 2: DNA Extraction The DNA is extracted from the collected tissue sample. This step is crucial as it isolates the genetic material needed for the promoter methylation profiling of the specified genes.
• Step 3: Real-Time PCR Analysis The extracted DNA undergoes real-time PCR to assess the methylation status of the three genes: GSTP1, APC, and RASSF1. This technique allows for the amplification and quantification of specific DNA sequences, providing insights into the methylation patterns associated with prostate cancer.
• Step 4: Algorithm Scoring Following the PCR analysis, an algorithm is applied to interpret the results. This algorithm calculates a score that reflects the likelihood of prostate cancer detection on repeat biopsy based on the methylation status of the analyzed genes.
• Step 5: Reporting The final step involves generating a report that details the findings of the methylation profiling and the calculated likelihood score. This report is then provided to the healthcare provider for further clinical decision-making.

3. Post-Procedure

After the completion of the procedure associated with CPT® Code 81551, there are several considerations for post-procedure care. The results of the methylation profiling will be reviewed by the healthcare provider, who will discuss the findings with the patient. Depending on the likelihood score reported, further diagnostic procedures, such as repeat biopsies or additional imaging studies, may be recommended. It is essential for patients to have a follow-up appointment to discuss the implications of the test results and to determine the appropriate next steps in their care plan. Additionally, patients should be monitored for any symptoms that may arise during this period, and any concerns should be promptly addressed by their healthcare provider.